Welcure Drugs & Pharmaceuticals Secures Major Export Orders

Welcure Drugs & Pharmaceuticals has landed two substantial export orders valued at Rs 85.6 crore, the company announced on Tuesday. The orders, secured from Giant Exim and Ravina International, each amount to Rs 42.8 crore, specifically for the procurement and consolidation of mycorrhizal inoculant.

The company emphasized that these orders will contribute to fee-based revenue, eliminating inventory and logistics risks. Welcure is also in advanced discussions with additional international clients to secure further export mandates worth Rs 20 crore or more within the current quarter.

Moreover, Welcure has recently obtained a significant Rs 517 crore global sourcing mandate from Thailand-based Fortune Sagar Impex Company. The company continues to focus on expanding its fee-based export portfolio while ensuring a debt-free capital structure.

(With inputs from agencies.)